The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Clifford Chance has become embroiled in a bizarre case with a former client that is accusing the magic circle firm of fraudulent billing and malpractice. The lawsuit, filed by Mylan Pharmaceuticals on 8 August, arose as a result of an antitrust case that Clifford Chance's US office had acted on since 1999 and which settled last year. Mylan is claiming that the firm acted wrongly on the settlement and the $19m (£11.8m) fee was too high. Mylan is claiming damages, although it has not specified the amount. In a strange twist, it emerged that Mylan has brought a suit against New York white collar crime firm Morvillo Abramowitz Grand Iason & Silberberg, which was involved in the same case. The timing is unfortunate, as it comes less than a year after Clifford Chance's New York associates penned a damning memo, which said the firm encouraged the 'padding of hours'. Chris Perrin, Clifford Chance executive partner, said that Morvillo was brought in by Mylan to supervise Clifford Chance. Mylan made the filing against the US firm in February, but Morvillo, who is currently representing Martha Stewart and who also acted for Merrill Lynch against claims by New York Attorney-General Eliot Spitzer, is fighting the suit. It filed for a dismissal in July. Perrin said Clifford Chance was in receipt of the lawsuit, but it would vigor-ously defend Mylan's claims. Mylan and Morvillo were unavailable for comment.